Next Article in Journal
Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance
Previous Article in Journal
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis
Previous Article in Special Issue
In Vitro–In Vivo Relationship in Mini-Scale—Enabling Formulations of Corallopyronin A
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(9), 1807; https://doi.org/10.3390/pharmaceutics14091807
Action Date Notes Link
article pdf uploaded. 27 August 2022 15:55 CEST Version of Record https://www.mdpi.com/1999-4923/14/9/1807/pdf-vor
article xml file uploaded 1 September 2022 06:57 CEST Original file -
article xml uploaded. 1 September 2022 06:57 CEST Update https://www.mdpi.com/1999-4923/14/9/1807/xml
article pdf uploaded. 1 September 2022 06:57 CEST Updated version of record https://www.mdpi.com/1999-4923/14/9/1807/pdf
article html file updated 1 September 2022 06:58 CEST Original file -
article html file updated 1 September 2022 07:02 CEST Update -
article html file updated 1 September 2022 10:03 CEST Update https://www.mdpi.com/1999-4923/14/9/1807/html
Back to TopTop